{
  "main_header": {
    "sid": 1289754,
    "name": "Mineralys Therapeutics, Inc.",
    "stock_name": "Mineralys Therapeutics, Inc.",
    "full_name": "Mineralys Therapeutics, Inc.",
    "name_url": "stocks-analysis/mineralys-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "38.91",
    "chg": -0.24,
    "chgp": "-0.61%",
    "dir": -1,
    "prev_price": "39.15",
    "mcapval": "2,734.24",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US6031701013",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "2.09 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mineralys-therapeutics-inc-1289754-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Mineralys Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mineralys-therapeutics-inc-technically-bullish-or-bearish-3599383",
        "imagepath": "",
        "date": "2025-10-07 12:25:42",
        "description": "As of 3 October 2025, the technical trend for Mineralys Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD indicates a bullish stance, while the RSI shows bearish conditions for both weekly and monthly periods. The Bollinger Bands reflect a mildly bullish trend on the weekly and a bullish trend on the monthly. Daily moving averages are bullish, but the KST is mildly bearish on the weekly. Dow Theory and OBV show no trend in both weekly and monthly analyses.\n\nIn terms of performance, the stock has returned 208.77% year-to-date and 173.85% over the past year, significantly outperforming the S&P 500, which returned 14.18% and 17.82% respectively. Overall, the current technical stance is mildly bullish, driven primarily by the bullish daily moving averages and the weekly MACD...."
      },
      {
        "title": "Is Mineralys Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mineralys-therapeutics-inc-technically-bullish-or-bearish-3592183",
        "imagepath": "",
        "date": "2025-10-05 12:01:22",
        "description": "As of 3 October 2025, the technical trend for Mineralys Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the weekly RSI is bearish, indicating mixed signals. The Bollinger Bands show a mildly bullish stance on the weekly chart and bullish on the monthly. Daily moving averages are bullish, but the KST and OBV on the weekly are mildly bearish, suggesting some caution. \n\nIn terms of performance, the stock has returned 30.12% over the past month compared to the S&P 500's 4.15%, and a remarkable 209.18% year-to-date versus the S&P's 14.18%. Overall, the current technical stance is mildly bullish, driven by the daily moving averages and weekly MACD, despite bearish signals from the RSI and KST...."
      },
      {
        "title": "Is Mineralys Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mineralys-therapeutics-inc-technically-bullish-or-bearish-3548330",
        "imagepath": "",
        "date": "2025-09-20 20:15:06",
        "description": "As of 2 September 2025, the technical trend for Mineralys Therapeutics, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish with strong indicators. The weekly MACD is bullish, and both the Bollinger Bands and Dow Theory are also indicating bullish trends. However, the weekly RSI is bearish, which suggests some caution. The daily moving averages are bullish, supporting the overall positive outlook. \n\nIn terms of performance, the company has significantly outperformed the S&P 500 across multiple periods, with a 1-month return of 159.91% compared to the S&P 500's 2.33%, and a year-to-date return of 223.88% versus 12.22%...."
      },
      {
        "title": "Mineralys Therapeutics Hits New 52-Week High at $40.33, Up 195%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mineralys-therapeutics-hits-new-52-week-high-at-4033-up-195-3537174",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/MineralysTherap_priceRelatedfactors_3537174.png",
        "date": "2025-09-19 13:15:52",
        "description": "Mineralys Therapeutics, Inc. achieved a new 52-week high of USD 40.33 on September 18, 2025, reflecting a 195.33% increase over the past year. The company, with a market cap of USD 2,734 million, operates in the Pharmaceuticals & Biotechnology sector and currently reports losses."
      }
    ],
    "total": 7,
    "sid": "1289754",
    "stock_news_url": "https://www.marketsmojo.com/news/mineralys-therapeutics-inc-1289754"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Mineralys Therapeutics, Inc. technically bullish or bearish?

2025-10-07 12:25:42

As of 3 October 2025, the technical trend for Mineralys Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD indicates a bullish stance, while the RSI shows bearish conditions for both weekly and monthly periods. The Bollinger Bands reflect a mildly bullish trend on the weekly and a bullish trend on the monthly. Daily moving averages are bullish, but the KST is mildly bearish on the weekly. Dow Theory and OBV show no trend in both weekly and monthly analyses. In terms of performance, the stock has returned 208.77% year-to-date and 173.85% over the past year, significantly outperforming the S&P 500, which returned 14.18% and 17.82% respectively. Overall, the current technical stance is mildly bullish, driven primarily by the bullish daily moving averages and the weekly MACD....

Read More

Is Mineralys Therapeutics, Inc. technically bullish or bearish?

2025-10-05 12:01:22

As of 3 October 2025, the technical trend for Mineralys Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the weekly RSI is bearish, indicating mixed signals. The Bollinger Bands show a mildly bullish stance on the weekly chart and bullish on the monthly. Daily moving averages are bullish, but the KST and OBV on the weekly are mildly bearish, suggesting some caution. In terms of performance, the stock has returned 30.12% over the past month compared to the S&P 500's 4.15%, and a remarkable 209.18% year-to-date versus the S&P's 14.18%. Overall, the current technical stance is mildly bullish, driven by the daily moving averages and weekly MACD, despite bearish signals from the RSI and KST....

Read More

Is Mineralys Therapeutics, Inc. technically bullish or bearish?

2025-09-20 20:15:06

As of 2 September 2025, the technical trend for Mineralys Therapeutics, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish with strong indicators. The weekly MACD is bullish, and both the Bollinger Bands and Dow Theory are also indicating bullish trends. However, the weekly RSI is bearish, which suggests some caution. The daily moving averages are bullish, supporting the overall positive outlook. In terms of performance, the company has significantly outperformed the S&P 500 across multiple periods, with a 1-month return of 159.91% compared to the S&P 500's 2.33%, and a year-to-date return of 223.88% versus 12.22%....

Read More

Mineralys Therapeutics Hits New 52-Week High at $40.33, Up 195%

2025-09-19 13:15:52

Mineralys Therapeutics, Inc. achieved a new 52-week high of USD 40.33 on September 18, 2025, reflecting a 195.33% increase over the past year. The company, with a market cap of USD 2,734 million, operates in the Pharmaceuticals & Biotechnology sector and currently reports losses.

Read More

View All News